Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    February 2017
  1. KRISTENSEN VN
    The Antigenicity of the Tumor Cell - Context Matters.
    N Engl J Med. 2017;376:491-493.
    PubMed     Text format    


    January 2017
  2. COPUR MS, Ramaekers R, Crockett D
    Ipilimumab Adjuvant Therapy in Melanoma.
    N Engl J Med. 2017;376:398-9.
    PubMed     Text format    


  3. IANIRO G, Gasbarrini A, Cammarota G
    Ipilimumab Adjuvant Therapy in Melanoma.
    N Engl J Med. 2017;376:398.
    PubMed     Text format    


  4. EGGERMONT AMM, Suciu S, Testori A, et al., et al
    Ipilimumab Adjuvant Therapy in Melanoma.
    N Engl J Med. 2017;376:399.
    PubMed     Text format    


    November 2016
  5. JOHNSON DB, Balko JM, Compton ML, Chalkias S, et al
    Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
    N Engl J Med. 2016;375:1749-1755.
    PubMed     Text format     Abstract available


    October 2016
  6. EGGERMONT AM, Chiarion-Sileni V, Grob JJ, Dummer R, et al
    Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    August 2016
  7. WELLBROCK C
    Melanoma and the Microenvironment--Age Matters.
    N Engl J Med. 2016;375:696-8.
    PubMed     Text format    


    July 2016
  8. DE MALEISSYE MF, Nicolas G, Saiag P
    Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.
    N Engl J Med. 2016;375:296-7.
    PubMed     Text format    


  9. ZARETSKY JM, Garcia-Diaz A, Shin DS, Escuin-Ordinas H, et al
    Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  10. MARCHALIK RJ, Venna S
    IMAGES IN CLINICAL MEDICINE. Eyelid Melanoma.
    N Engl J Med. 2016;375:75.
    PubMed     Text format    


    June 2016
  11. MINAGAWA A, Omodaka T, Okuyama R
    Melanomas and Mechanical Stress Points on the Plantar Surface of the Foot.
    N Engl J Med. 2016;374:2404-6.
    PubMed     Text format    


    April 2016
  12. VERA-KELLET C, Del Barrio-Diaz P
    IMAGES IN CLINICAL MEDICINE. Oral Amalgam Tattoo Mimicking Melanoma.
    N Engl J Med. 2016;374:e21.
    PubMed     Text format    


    March 2016
  13. JANSEN T, Hoff NP
    IMAGES IN CLINICAL MEDICINE. Diffuse Melanosis Cutis.
    N Engl J Med. 2016;374:1177.
    PubMed     Text format    


  14. LIPSKER D
    The Genetic Evolution of Melanoma.
    N Engl J Med. 2016;374:993-6.
    PubMed     Text format     Abstract available


  15. LIAN CG, Murphy GF
    The Genetic Evolution of Melanoma.
    N Engl J Med. 2016;374:993-6.
    PubMed     Text format     Abstract available


  16. CRISCITO MC, Polsky D, Stein JA
    The Genetic Evolution of Melanoma.
    N Engl J Med. 2016;374:993-6.
    PubMed     Text format     Abstract available



  17. The Genetic Evolution of Melanoma.
    N Engl J Med. 2016;374:993-6.
    PubMed     Text format     Abstract available


  18. VOGELSTEIN B, Kinzler KW
    The Genetic Evolution of Melanoma.
    N Engl J Med. 2016;374:996.
    PubMed     Text format    


    November 2015
  19. CHAN TA, Wolchok JD, Snyder A
    Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma.
    N Engl J Med. 2015;373:1984.
    PubMed     Text format    


  20. SHAIN AH, Yeh I, Kovalyshyn I, Sriharan A, et al
    The Genetic Evolution of Melanoma from Precursor Lesions.
    N Engl J Med. 2015;373:1926-36.
    PubMed     Text format     Abstract available


  21. WARREN MP, Harvey VM
    IMAGES IN CLINICAL MEDICINE. Acral Lentiginous Melanoma.
    N Engl J Med. 2015;373:1864.
    PubMed     Text format    


    September 2015
  22. VALSECCHI ME
    Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
    N Engl J Med. 2015;373:1270.
    PubMed     Text format    


  23. LARKIN J, Hodi FS, Wolchok JD
    Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
    N Engl J Med. 2015;373:1270-1.
    PubMed     Text format    


    July 2015
  24. SHARFSTEIN JM
    A Spotlight on Sunscreen Regulation.
    N Engl J Med. 2015;373:101-3.
    PubMed     Text format    


    May 2015
  25. LARKIN J, Chiarion-Sileni V, Gonzalez R, Grob JJ, et al
    Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  26. SONG JY
    Intraoral malignant melanoma.
    N Engl J Med. 2015;372:1944.
    PubMed     Text format     Abstract available


  27. MCINNES CW, Bellan L
    Images in clinical medicine. Conjunctival melanoma.
    N Engl J Med. 2015;372:1844.
    PubMed     Text format    


    April 2015
  28. CHAPMAN PB, D'Angelo SP, Wolchok JD
    Rapid Eradication of a Bulky Melanoma Mass with One Dose of Immunotherapy.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  29. POSTOW MA, Chesney J, Pavlick AC, Robert C, et al
    Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  30. ROBERT C, Schachter J, Long GV, Arance A, et al
    Pembrolizumab versus Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


    February 2015
  31. MELERO I, Lasarte JJ
    Genetic basis for clinical response to CTLA-4 blockade.
    N Engl J Med. 2015;372:783.
    PubMed     Text format    


  32. SNYDER A, Wolchok JD, Chan TA
    Genetic basis for clinical response to CTLA-4 blockade.
    N Engl J Med. 2015;372:783.
    PubMed     Text format    


    January 2015
  33. SZNOL M, Longo DL
    Release the hounds! Activating the T-cell response to cancer.
    N Engl J Med. 2015;372:374-5.
    PubMed     Text format    


    November 2014
  34. BOUSSIOTIS VA
    Somatic Mutations and Immunotherapy Outcome with CTLA-4 Blockade in Melanoma.
    N Engl J Med. 2014.
    PubMed     Text format     Abstract available


  35. SNYDER A, Makarov V, Merghoub T, Yuan J, et al
    Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma.
    N Engl J Med. 2014.
    PubMed     Text format     Abstract available


  36. ROBERT C, Long GV, Brady B, Dutriaux C, et al
    Nivolumab in Previously Untreated Melanoma without BRAF Mutation.
    N Engl J Med. 2014.
    PubMed     Text format     Abstract available


  37. ROBERT C, Karaszewska B, Schachter J, Rutkowski P, et al
    Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib.
    N Engl J Med. 2014.
    PubMed     Text format     Abstract available


  38. CURTI BD
    Rapid evolution of combination therapy in melanoma.
    N Engl J Med. 2014;371:1929-30.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: